Edition:
United States

Histogenics Corp (HSGX.OQ)

HSGX.OQ on NASDAQ Stock Exchange Capital Market

1.86USD
15 Dec 2017
Change (% chg)

$0.05 (+2.76%)
Prev Close
$1.81
Open
$1.81
Day's High
$1.87
Day's Low
$1.80
Volume
8,395
Avg. Vol
12,929
52-wk High
$2.40
52-wk Low
$1.45

Select another date:

Thu, Nov 9 2017

BRIEF-Histogenics Corp announces Q3 loss per share $0.23

* Histogenics Corporation announces third quarter 2017 financial and operating results

BRIEF-Histogenics Corp promotes Stephen Kennedy to COO

* Histogenics Corporation promotes Stephen Kennedy to executive vice president & chief operating officer Source text for Eikon: Further company coverage:

BRIEF-Histogenics says Q2 loss per share $0.25

* Histogenics corporation announces second quarter 2017 financial and operating results

BRIEF-Histogenics on track for top-line one year superiority data, potential BLA filing in Q3 of 2018

* Histogenics completes enrollment for phase 3 clinical trial of neocart® to treat knee cartilage damage

Select another date: